Trial Profile

A study assessing VBI-1901 for glioblastoma

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 29 Jun 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs VBI 1901 (Primary)
Indications Glioblastoma
Focus Registrational; Therapeutic Use
Sponsors VBI Vaccines

Most Recent Events

22 Jun 2022 According to a VBI Vaccines media release, the company expect to initiate this trial in Q3 2022 and this trial will support accelerated approval application.
08 Nov 2021 According to a VBI Vaccines media release, this study is anticipated to begin in mid-year 2022.
10 May 2021 According to a VBI Vaccines media release, this study is anticipated to begin in the Q4 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com